SCHEMBL18178391

SCHEMBL18178391

CCc1cc(C)c(C)cc1OCc1c(CC)cccc1OC(=O)OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 2/20 0.36
RAB9A P51151 2/20 0.36
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SLC22A12 Q96S37 1/20 0.36
PTPN1 P18031 1/20 0.36
PDE5A O76074 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LTB4R Q15722 1/20 0.35
LTB4R2 Q9NPC1 1/20 0.35
FABP4 P15090 1/20 0.34
FABP5 Q01469 1/20 0.34
PDCD1 Q15116 2/20 0.34
CD274 Q9NZQ7 2/20 0.34
PTGDR2 Q9Y5Y4 2/20 0.34
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178394 0.94 KDM4E (0.35) KDM4EHPGDHSD17B10MAPTRAB9A
SCHEMBL18182414 0.94 KDM4E (0.37) KDM4EHPGDHSD17B10MAPTRAB9A
SCHEMBL18178395 0.93 KDM4E (0.35) KDM4EHPGDHSD17B10MAPTRAB9A
SCHEMBL18178384 0.93 MAPT (0.43) KDM4EHPGDHSD17B10MAPTRAB9A
SCHEMBL18178387 0.93 SLC22A12 (0.41) KDM4EHPGDHSD17B10MAPTRAB9A
SCHEMBL18182406 0.91 SLC22A12 (0.38) KDM4EHPGDHSD17B10MAPTRAB9A
SCHEMBL18178295 0.91 MRGPRX4 (0.39) KDM4EHPGDHSD17B10MAPTRAB9A
SCHEMBL18178194 0.91 MRGPRX4 (0.37) KDM4EHPGDHSD17B10MAPTRAB9A
SCHEMBL18178392 0.90 MRGPRX4 (0.38) KDM4EHPGDHSD17B10MAPTRAB9A
SCHEMBL18178388 0.89 LMNA (0.36) KDM4EHPGDHSD17B10MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 KDM4E 2107/4885HPGD 4638/4885HSD17B10 2873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.